AU2003294696A1 - Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylytransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases - Google Patents
Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylytransferase 2 (nmnat-2) gene and protein for neurodegenerative diseasesInfo
- Publication number
- AU2003294696A1 AU2003294696A1 AU2003294696A AU2003294696A AU2003294696A1 AU 2003294696 A1 AU2003294696 A1 AU 2003294696A1 AU 2003294696 A AU2003294696 A AU 2003294696A AU 2003294696 A AU2003294696 A AU 2003294696A AU 2003294696 A1 AU2003294696 A1 AU 2003294696A1
- Authority
- AU
- Australia
- Prior art keywords
- adenylytransferase
- nmnat
- diagnostic
- gene
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108090000623 proteins and genes Proteins 0.000 title 2
- DAYLJWODMCOQEW-TURQNECASA-O NMN(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(O)=O)O2)O)=C1 DAYLJWODMCOQEW-TURQNECASA-O 0.000 title 1
- 230000004770 neurodegeneration Effects 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41872102P | 2002-10-17 | 2002-10-17 | |
| EP02023272 | 2002-10-17 | ||
| EP02023272.4 | 2002-10-17 | ||
| US60/418,721 | 2002-10-17 | ||
| PCT/EP2003/011478 WO2004035823A2 (en) | 2002-10-17 | 2003-10-16 | Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylytransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003294696A1 true AU2003294696A1 (en) | 2004-05-04 |
| AU2003294696A8 AU2003294696A8 (en) | 2004-05-04 |
Family
ID=56290494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003294696A Abandoned AU2003294696A1 (en) | 2002-10-17 | 2003-10-16 | Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylytransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1552310A2 (en) |
| AU (1) | AU2003294696A1 (en) |
| WO (1) | WO2004035823A2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0902147D0 (en) * | 2009-02-10 | 2009-03-25 | Babraham Inst | NMNAT2 modulator |
| GB201006961D0 (en) * | 2010-04-27 | 2010-06-09 | Babraham Inst | NMN modulator |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2393002A1 (en) * | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
-
2003
- 2003-10-16 EP EP03785626A patent/EP1552310A2/en not_active Withdrawn
- 2003-10-16 AU AU2003294696A patent/AU2003294696A1/en not_active Abandoned
- 2003-10-16 WO PCT/EP2003/011478 patent/WO2004035823A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1552310A2 (en) | 2005-07-13 |
| WO2004035823A3 (en) | 2004-07-22 |
| WO2004035823A2 (en) | 2004-04-29 |
| AU2003294696A8 (en) | 2004-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL157364A0 (en) | Therapeutic methods and agents for diseases associated with decreased expression of aop-1 gene or aop-1 | |
| AU2003223579A1 (en) | Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease | |
| AU2003261237A1 (en) | Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases | |
| AU2002952993A0 (en) | Therapeutic and diagnostic agents | |
| AU2002226690A1 (en) | Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases | |
| AU2002258728A1 (en) | Gene brcc-3 and diagnostic and therapeutic uses thereof | |
| AU2002305151A1 (en) | Gene scc-112 and diagnostic and therapeutic uses thereof | |
| AU2002303261A1 (en) | Gene brcc2 and diagnostic and therapeutic uses thereof | |
| AU2003267532A1 (en) | PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASES | |
| AU2003268295A1 (en) | "diagnosis and treatment of infertility" | |
| AU2003209150A1 (en) | Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases | |
| AU2003260301A1 (en) | Diagnostic and therapeutic use of ensadin-0581 gene and protein for neurodegenerative diseases | |
| AU2003246592A1 (en) | Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases | |
| AU2003278497A1 (en) | Diagnostic and therapeutic use of ras-gtpase-activating sh3-domain-binding protein 2 (g3bp2) for neurodegenerative diseases | |
| AU2003279312A1 (en) | Diagnostic and therapeutic use of ensadin-0289 gene and protein for neurodegenerative diseases | |
| AU2003294696A1 (en) | Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylytransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases | |
| AU2003263036A1 (en) | SPAN-Xb GENE AND PROTEIN FOR THE DIAGNOSIS AND TREATMENT OF CANCER | |
| AU2002303262A1 (en) | Gene shinc-1 and diagnostic and therapeutic uses thereof | |
| AU5611701A (en) | Agent for the diagnosis and therapy of viral diseases | |
| AU2002364757A1 (en) | Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases | |
| AU2003288127A1 (en) | DIAGNOSTIC AND THERAPEUTIC USE OF H-Rev107 PROTEIN FOR ALZHEIMER DISEASE | |
| AU2003224080A1 (en) | Diagnostic and therapeutic use of a golgi protein for neurodegenerative diseases | |
| AU2003222849A1 (en) | Diagnostic and therapeutic use of ensadin-0255 gene and protein for neurodegenerative diseases | |
| AU2003242588A1 (en) | Diagnostic and therapeutic use of cyp11a1 for neurodegenerative diseases | |
| AU2003224095A1 (en) | Diagnostic and therapeutic use of an atp-binding cassette gene and protein for neurodegenerative diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |